Open Demat Account
Become a
New
Partner
Financial
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
PMS
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
Alternative Investment Funds
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Bulk Drugs & Formln
Share
Syncom Formulations (India) Ltd Share Price
Pharmaceuticals - Indian - Bulk Drugs & Formln
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
11.30
11.30
Date :
Apr 02,2026 EOD
+0.13
(1.16 )
+0.98
(0.11 )
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
11.00
Buy (size)
11.30(x53)
Sell (size)
0.00(×0)
Buy Qty
53
Sell Qty
0
Today's High
(₹)
11.50
Today's Low
(₹)
10.72
52 Week High
(₹)
23.49
52 Week Low
(₹)
10.21
Market Statistics
Div Yield (%)
0
EPS
0.73
Book Value
4.03
Market Cap
1062.2
Face Value
1
Market Lot
1
AGM Date
Sep
Closure Date
Sep
ISIN No
INE312C01025
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
475347599
Total of Promoter
475347599
Non Promoter (Institution)
2477426
Non Promoter (Non-Institution)
462174975
Total Non Promoter
464652401
Total Promoter & Non Promoter
940000000
Custodians(Against Depository Receipts)
0
Grand Total
940000000
News
Syncom Formulations (India) Ltd
Syncom Formulations (India) consolidated net ..
12-Feb-2026
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter
Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024.
Particulars
Quarter Ended
Dec. 2025
Dec. 2024
% Var.
Sales
115.14
127.53
-10
OPM %
18.42
11.55
-
PBDT
26.45
18.57
42
PBT
25.09
17.26
45
NP
18.91
13.00
45
Syncom Formulations (India) Ltd
Syncom Formulations (India) to convene board ..
04-Feb-2026
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) to convene board meeting
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 February 2026.
Syncom Formulations (India) Ltd
Syncom Formulations (India) consolidated net ..
13-Nov-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) consolidated net profit rises 49.41% in the September 2025 quarter
Net profit of Syncom Formulations (India) rose 49.41% to Rs 16.60 crore in the quarter ended September 2025 as against Rs 11.11 crore during the previous quarter ended September 2024. Sales rose 18.97% to Rs 121.72 crore in the quarter ended September 2025 as against Rs 102.31 crore during the previous quarter ended September 2024.
Particulars
Quarter Ended
Sep. 2025
Sep. 2024
% Var.
Sales
121.72
102.31
19
OPM %
15.12
11.89
-
PBDT
23.39
16.15
45
PBT
22.04
14.85
48
NP
16.60
11.11
49
Syncom Formulations (India) Ltd
Syncom Formulations (India) announces board m..
08-Nov-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) announces board meeting date
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 November 2025.
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder Meeting / Postal Ballot-Scrutinizers Report
Submission of Results for the 37th Annual general meeting held on 29th Sep 2025
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 37th Annual General meeting held on 29th Sep 2025
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Change in Management_Appointment of Chairman and Secreterial Auditor as confirmed in the 37th Annual general Meeting
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Alteration in MOA and AOA as approved in the 37th AGM
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Secretarial Auditor confirmed in 37th AGM
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Syncom Form..
24-Sep-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Trading Window
Syncom Formulations (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Corporate Details
Board of Directors
Incorporation Year
1988
Chairman
ANKIT KEDARMAL BANKDA
Auditor
Sanjay Mehta & Associates
Face Value
1
Market Lot
1
Listing
BSE,NSE,
Registered Office
207 Saket Nagar Near Saket Club  MP Madhya Pradesh Indore452001
Contact
Telephone: 91-22-30887744
Fax: 91-22-30887755
Chairman & Exec. Director
Kedarmal Bankda
ED / MD / Promoter
Vijay Bankda
Independent Non Exe. Director
Ruchi Jindal
Ritesh Kumar Lunkad
Ankit Jain
Chairman / Executive Director / WTD
ANKIT KEDARMAL BANKDA
Company Sec. & Compli. Officer
Vaishali Agrawal
Mutual Fund Holdings
1-2
of 2
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
Motilal Oswal BSE Healthcare ETF
0.02
0.04
42.77
Bandhan BSE Healthcare Index Fund
0.01
0.04
16.75
FAQ
What is the share price of Syncom Formulations (India) Ltd today on NSE and BSE?
The Syncom Formulations (India) Ltd Share price on NSE is Rs.11.30 and BSE Rs.11.30 as on today
How to buy Syncom Formulations (India) Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Syncom Formulations (India) Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Syncom Formulations (India) Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Syncom Formulations (India) Ltd is 1062.2
What are the key financial ratios to analyse Syncom Formulations (India) Ltd Share Price?
Syncom Formulations (India) Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 15.48
ROE ratio: 15.6
Debt to Equity ratio: 0.12
EPS: 0.73
When did Syncom Formulations (India) Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Syncom Formulations (India) Ltd issued bonus shares last in 2013
What is the 52 week highest and lowest share price value of Syncom Formulations (India) Ltd?
The highest share price value is Rs. 23.49 and Lowest share price value is Rs. 10.21 for 52 week period for Syncom Formulations (India) Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Syncom Formulations (India) Ltd?
Motilal Oswal BSE Healthcare ETF has the highest amount invested with Syncom Formulations (India) Ltd.
Which year Syncom Formulations (India) Ltd was incorporated?
Syncom Formulations (India) Ltd was incorporated in 1988
What is the stock symbol of Syncom Formulations (India) Ltd?
The stock symbol for Syncom Formulations (India) Ltd shares is SYNCOMFORMULATIONS(INDIA)LTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
Aarti Pharmalabs Ltd
543748
AARTIPHARM
Accent Microcell Ltd
92465
ACCENTMIC
Accretion Pharmaceuticals Ltd
94000
ACCPL
Achyut Healthcare Ltd
543499
Not Listed
Advanced Enzyme Technologies Ltd
540025
ADVENZYMES
Akums Drugs & Pharmaceuticals Ltd
544222
AKUMS
Albert David Ltd
524075
ALBERTDAVD
Alembic Pharmaceuticals Ltd
533573
APLLTD
Alivus Life Sciences Ltd
543322
ALIVUS
Alkem Laboratories Ltd
539523
ALKEM
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
02 Apr 2026
1,988,425.00
921,567.00
46.35
01 Apr 2026
2,353,476.00
1,327,364.00
56.40
30 Mar 2026
3,369,066.00
2,056,062.00
61.03
27 Mar 2026
3,013,932.00
2,134,784.00
70.83
25 Mar 2026
1,536,898.00
934,791.00
60.82
24 Mar 2026
2,136,763.00
974,634.00
45.61
23 Mar 2026
1,936,298.00
1,338,200.00
69.11
20 Mar 2026
1,783,634.00
907,964.00
50.91
19 Mar 2026
1,249,601.00
737,778.00
59.04
18 Mar 2026
1,565,404.00
860,768.00
54.99
17 Mar 2026
3,200,427.00
2,046,693.00
63.95
16 Mar 2026
1,866,683.00
920,629.00
49.32
13 Mar 2026
1,658,924.00
911,879.00
54.97
12 Mar 2026
1,077,899.00
426,057.00
39.53
11 Mar 2026
1,621,223.00
727,109.00
44.85
10 Mar 2026
1,209,876.00
610,356.00
50.45
09 Mar 2026
1,167,810.00
630,867.00
54.02
06 Mar 2026
1,040,334.00
639,718.00
61.49
05 Mar 2026
2,006,362.00
1,044,337.00
52.05
Please wait ...